Research output per year
Research output per year
Fingerprint
Dive into the research topics where Simon Peter Gampenrieder is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
A comparison of breast cancer incidence and cancer stages before and after the introduction of the Austrian national breast cancer screening program in the federal state of Salzburg: Real-world data from the Tumor Registry Salzburg
Gampenrieder, S. P. (First author), Vaisband, M. (Co-author), Rinnerthaler, G. (Co-author), Weiss, L. (Co-author), Jaud, B., Sprenger, M. & Greil, R. (Last author), Apr 2025, In: WIENER KLINISCHE WOCHENSCHRIFT. 137, 7-8, p. 205-213 9 p.Research output: Contribution to journal › Original Article › peer-review
Open Access1 Citation (Web of Science) -
Different Types Of Electrostimulation Target Specific Impaired Sensory And Motor Functions In Chemotherapy-Induced Peripheral Neuropathy
Lawrenson, T. W. (First author), Rieder, F., Sassmann, R., Gampenrieder, S. P., Johansson, T., Rinnerthaler, G., Castagnaviz, V., Kienberger, Y., Flamm, M., Schaffler-Schaden, D., Greil, R. & Schulze, C., 2025.Research output: Contribution to conference › Abstract › peer-review
-
Electrotherapy as Treatment For Chemotherapy-Induced Peripheral Neuropathy—A Randomized Controlled Trial
Rieder, F. (First author), Gampenrieder, S. P. (Co-author), Sassmann, R. (Co-author), Schulze, C., Johansson, T., Rinnerthaler, G., Castagnaviz, V. (Co-author), Lampl, K. (Co-author), Herfert, J. (Co-author), Kienberger, Y., Flamm, M., Schaffler-Schaden, D. & Greil, R., 2025.Research output: Contribution to conference › Abstract › peer-review
-
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis
Niedersuess-Beke, D., Mayrhofer, K., Krauter, J., Franke, J., Vais, D., Pallauf, M. (Co-author), Kiesl, D., Luger, F., Pfuner, J., Terbuch, A., Bauernhofer, T., Spielgelberg, J., Banner, A., Aufderklamm, S., Wiesinger, C., Schnabel, S., Gampenrieder, S. P. (Co-author), Muhlmann, J., Vallet, S. & Weibrecht, S. & 11 others, , 22 Oct 2025, In: INTERNATIONAL JOURNAL OF CANCER. 12 p.Research output: Contribution to journal › Original Article › peer-review
Open Access -
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G. (First author), Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P. (Co-author), Knauer, M., Sotlar, K. (Co-author), Brunner, C. (Co-author), Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. & 10 others, , 16 Jan 2025, In: NATURE CANCER. 13 p.Research output: Contribution to journal › Original Article › peer-review
Open Access2 Citations (Web of Science)
-
Chemotherapy Induced Peripheral Neuropathy (CIPN) - Risk Prediction and Treatment
Rieder, F. (Project Applicant), Gampenrieder, S. P. (Project Applicant), Schaffler-Schaden, D. (Project Applicant), Jäger, S. (Project Applicant), Castagnaviz, V. (Project Applicant), Schulze, C. (Coordinating investigator), Lenzhofer, C. (Sub-investigator) & Sassmann, R. (Sub-investigator)
Project: Clinical study beyond AMG/MPG
-
The effect of high tone therapy in chemotherapy-induced peripheral neuropathy (HIT-CIPN)
Schaffler-Schaden, D. (Further contributor), Johansson, T. (CoPI), Gampenrieder, S. P. (CoPI), Rinnerthaler, G. (Further contributor), Lampl, K. (Further contributor), Greil, R. (Further contributor), Flamm, M. (Further contributor), Dengg, N. (Further contributor), Sassmann, R. (PI), Herfert, J. (Further contributor), Niebauer, J. (Further contributor), Rieder, F. (Further contributor) & Kienberger, Y. (Further contributor)
1/01/19 → 1/01/21
Project: Research
-
Analysis of circulating cell-free DNA to monitor tumor burden and treatment in head and neck cancer
Gampenrieder, S. P. (Further contributor), Hufnagl, C. (PI), Melchardt, T. (Further contributor), Magnes, T. (Further contributor), Rinnerthaler, G. (Further contributor), Egle, A. (Further contributor), Leisch, M. (Further contributor), Weiss, L. (Further contributor) & Greil, R. (Further contributor)
1/04/17 → 1/04/18
Project: Research
-
Tumor-infiltrierende Lymphozyten, Immuntherapie und Gensignaturen
Gampenrieder, S. P. (Invited speaker)
2016Activity: Talk or presentation › Oral presentation
-
CDK4/6: Intranukleäre vs. zytoplasmische Inhibition
Gampenrieder, S. P. (Invited speaker)
2016Activity: Talk or presentation › Oral presentation
-
BMC CANCER (Journal)
Gampenrieder, S. P. (Reviewer)
2015 → 2016Activity: Publication peer-review and editorial work › Publication Peer-review
-
Das triple-negative Mammakarzinom
Gampenrieder, S. P. (Invited speaker)
2015Activity: Talk or presentation › Oral presentation
-
Update HER2-Therapie: Ist weniger mehr? Ist es bereits Zeit für Deeskalation?
Gampenrieder, S. P. (Invited speaker)
2015Activity: Talk or presentation › Oral presentation